Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration
- PMID:29553577
- DOI: 10.1038/nbt.4114
Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration
Abstract
Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease progression. We engineered an RPE patch comprising a fully differentiated, human embryonic stem cell (hESC)-derived RPE monolayer on a coated, synthetic basement membrane. We delivered the patch, using a purpose-designed microsurgical tool, into the subretinal space of one eye in each of two patients with severe exudative AMD. Primary endpoints were incidence and severity of adverse events and proportion of subjects with improved best-corrected visual acuity of 15 letters or more. We report successful delivery and survival of the RPE patch by biomicroscopy and optical coherence tomography, and a visual acuity gain of 29 and 21 letters in the two patients, respectively, over 12 months. Only local immunosuppression was used long-term. We also present the preclinical surgical, cell safety and tumorigenicity studies leading to trial approval. This work supports the feasibility and safety of hESC-RPE patch transplantation as a regenerative strategy for AMD.
Comment in
- Retinal implants show promise in macular degeneration.Wood H.Wood H.Nat Rev Neurol. 2018 Jun;14(6):317. doi: 10.1038/s41582-018-0007-x.Nat Rev Neurol. 2018.PMID:29691492No abstract available.
Similar articles
- Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs.Koss MJ, Falabella P, Stefanini FR, Pfister M, Thomas BB, Kashani AH, Brant R, Zhu D, Clegg DO, Hinton DR, Humayun MS.Koss MJ, et al.Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1553-1565. doi: 10.1007/s00417-016-3386-y. Epub 2016 Jun 22.Graefes Arch Clin Exp Ophthalmol. 2016.PMID:27335025
- Longitudinal Evaluation of the Distribution of Intraretinal Hyper-Reflective Foci in Eyes with Intermediate Age-Related Macular Degeneration.Verma A, Nittala MG, Corradetti G, Nassisi M, Velaga SB, He Y, Haines JL, Pericak-Vance MA, Stambolian D, Sadda SR.Verma A, et al.Curr Eye Res. 2024 Dec;49(12):1278-1284. doi: 10.1080/02713683.2024.2343334. Epub 2024 Apr 19.Curr Eye Res. 2024.PMID:38639042
- Spatio-temporal alterations in retinal and choroidal layers in the progression of age-related macular degeneration (AMD) in optical coherence tomography.Vogl WD, Bogunović H, Waldstein SM, Riedl S, Schmidt-Erfurth U.Vogl WD, et al.Sci Rep. 2021 Mar 11;11(1):5743. doi: 10.1038/s41598-021-85110-y.Sci Rep. 2021.PMID:33707539Free PMC article.
- Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Bryant A, Hiu S, Kunonga PT, Gajjar K, Craig D, Vale L, Winter-Roach BA, Elattar A, Naik R.Bryant A, et al.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.Cochrane Database Syst Rev. 2022.PMID:36161421Free PMC article.Review.
- Platelet-rich therapies for musculoskeletal soft tissue injuries.Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC.Moraes VY, et al.Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD010071. doi: 10.1002/14651858.CD010071.pub3.Cochrane Database Syst Rev. 2014.PMID:24782334Free PMC article.Review.
Cited by
- Comparison of human amniotic membrane decellularisation approaches for hESC-derived RPE cells culture.Daniele E, Ferrari B, Rassu N, Ben-Nun J, Bosio L, Barbaro V, Ferrari S, Ponzin D.Daniele E, et al.BMJ Open Ophthalmol. 2022 Sep;7(1):e000981. doi: 10.1136/bmjophth-2022-000981.BMJ Open Ophthalmol. 2022.PMID:36161850Free PMC article.
- Tissue engineering RPE sheet derived from hiPSC-RPE cell spheroids supplemented with Y-27632 and RepSox.Wang W, Yang T, Chen S, Liang L, Wang Y, Ding Y, Xiong W, Ye X, Guo Y, Shen S, Chen H, Chen J.Wang W, et al.J Biol Eng. 2024 Jan 16;18(1):7. doi: 10.1186/s13036-024-00405-8.J Biol Eng. 2024.PMID:38229139Free PMC article.
- Recent Review on Biological Barriers and Host-Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies.Deshmukh R, Sethi P, Singh B, Shiekmydeen J, Salave S, Patel RJ, Ali N, Rashid S, Elossaily GM, Kumar A.Deshmukh R, et al.Pharmaceutics. 2024 Aug 16;16(8):1076. doi: 10.3390/pharmaceutics16081076.Pharmaceutics. 2024.PMID:39204421Free PMC article.Review.
- Low Immunogenicity and Immunosuppressive Properties of Human ESC- and iPSC-Derived Retinas.Yamasaki S, Sugita S, Horiuchi M, Masuda T, Fujii S, Makabe K, Kawasaki A, Hayashi T, Kuwahara A, Kishino A, Kimura T, Takahashi M, Mandai M.Yamasaki S, et al.Stem Cell Reports. 2021 Apr 13;16(4):851-867. doi: 10.1016/j.stemcr.2021.02.021. Epub 2021 Mar 25.Stem Cell Reports. 2021.PMID:33770500Free PMC article.
- Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials.Wang Y, Tang Z, Gu P.Wang Y, et al.Cell Death Dis. 2020 Sep 23;11(9):793. doi: 10.1038/s41419-020-02955-3.Cell Death Dis. 2020.PMID:32968042Free PMC article.Review.
References
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical